PDPH (3-(2-pyridyldithio)propionyl hydrazide)
PDPH (3-(2-pyridyldithio)propionyl hydrazide)
Thermo Scientific™

PDPH (3-(2-pyridyldithio)propionyl hydrazide)

Thermo Scientific Pierce PDPHは、短いピリジルジチオール基-ヒドラジド基間架橋剤で、スルフヒドリル基(システイン基)をカルボニル基(糖タンパク質の糖鎖の酸化によって形成されるアルデヒドやケトンなど)に結合させます詳細を見る
製品番号(カタログ番号)数量
2230150 mg
製品番号(カタログ番号) 22301
価格(JPY)
29,400
온라인 행사
Ends: 27-Mar-2026
49,000
割引額 19,600 (40%)
Each
お問い合わせください ›
数量:
50 mg
Thermo Scientific Pierce PDPHは、短いピリジルジチオール基-ヒドラジド基間架橋剤で、スルフヒドリル基(システイン基)をカルボニル基(糖タンパク質の糖鎖の酸化によって形成されるアルデヒドやケトンなど)に結合させます。

PDPHの特徴:

•反応基ピリジルジスルフィドヒドラジド
• 以下と反応:スルフヒドリル基およびカルボニル(アルデヒド)基
•ジスルフィド結合スペーサーアーム(切断可能)を持つ短い(9.2A)スルフヒドリル基-アルデヒド基間架橋剤
•ピリジルジチオール基、ジスルフィド結合を介してスルフヒドリル基に結合。DTT、TCEP、またはその他の還元剤で切断可能
•ヒドラジド基を糖タンパク質や糖質の酸化糖にコンジュゲート
メタ過ヨウ酸ナトリウムを使用してグリコシル化物(シアル酸など)を酸化して反応性アルデヒド基にする
EDCと併用してヒドラジド基の一級アミンをカルボキシル基に結合

製品リファレンス:
架橋剤アプリケーションガイド - この製品に関する最近の文献情報を検索
研究用途にのみご使用ください。診断目的には使用できません。
仕様
細胞透過性Yes
概要PDPH
形状Powder
標識法化学的標識
分子量229.32
PEG化No
製品ラインPierce
数量50 mg
反応性部分マレイミド、ピリジルジスルフィド
出荷条件Ambient
溶解性DMF、DMSO
スペーサーアーム長9.2 Å
水溶性No
化学反応性Carbohydrate-Sulfhydryl
CleavableBy Thiols
クロスリンカータイプヘテロ三官能性
フォーマットStandard
製品タイプ架橋剤
スペーサー切断可能、短
Unit SizeEach
組成および保存条件
受け取り後、乾燥した場所に4℃で保存。製品は室温で出荷されます。

よくあるご質問(FAQ)

Can you provide the shelf-life for PDPH (3-(2-pyridyldithio)propionyl hydrazide)?

PDPH (3-(2-pyridyldithio)propionyl hydrazide) is covered under our general 1-year warranty and is guaranteed to be fully functional for 12 months from the date of shipment, if stored as recommended. Please see section 8.1 of our Terms & Conditions of Sale (https://www.thermofisher.com/content/dam/LifeTech/Documents/PDFs/Terms-and-Conditions-of-Sale.pdf) for more details.

Find additional tips, troubleshooting help, and resources within our Protein Purification and Isolation Support Center.

We are using EDC to crosslink a protein onto carboxyl-modified beads. We would like to add in a linker molecule to extend the radius of beads to increase the surface area so more proteins can be immobilized. Is this possible?

To provide a linker between the beads and the target protein, you would need a molecule with a primary amine (to conjugate to the carboxyl group on the beads with EDC) on one end and another reactive group on the other (to conjugate to the protein). For instance, sulfo-SMCC (Cat. No. A39268) could be used in conjunction with PDPH (Cat. No. 22301):
The method is outlined below:
1. Conjugate the target protein to the NHS ester (amine-reactive) group of Sulfo-SMCC. This will produce a maleimide-activated target protein via its primary amines (lysines and N-terminus).
2. Remove the excess sulfo-SMCC by desalting or dialysis.
3. React the maleimide-activated target protein to PDPH via sulfhydryls. (Lysines and N-terminus now are connected to hydrazide (amine) group with an extended linker)
4. Remove excess PDPH by desalting or dialysis.
5. React the hydrazide-activated target protein with carboxyl beads in the presence of EDC.
6. Use appropriate buffer to rinse off excess target protein from the carboxyl beads.

Find additional tips, troubleshooting help, and resources within our Protein Purification and Isolation Support Center.

引用および参考文献 (3)

引用および参考文献
Abstract
Systemic administration of a nerve growth factor conjugate reverses age-related cognitive dysfunction and prevents cholinergic neuron atrophy.
Authors:Bäckman C, Rose GM, Hoffer BJ, Henry MA, Bartus RT, Friden P, Granholm AC
Journal:J Neurosci
PubMed ID:8757256
'Intraventricular administration of nerve growth factor (NGF) in rats has been shown to reduce age-related atrophy of central cholinergic neurons and the accompanying memory impairment. Intraventricular administration of NGF is necessary because NGF will not cross the blood-brain barrier (BBB). Here we have used a novel carrier system, consisting of ... More
Conjugation of folate via gelonin carbohydrate residues retains ribosomal-inactivating properties of the toxin and permits targeting to folate receptor positive cells.
Authors:Atkinson SF, Bettinger T, Seymour LW, Behr JP, Ward CM
Journal:J Biol Chem
PubMed ID:11359781
Conjugation of folate to proteins permits receptor-mediated endocytosis via the folate receptor (FR) and delivery of the conjugate into the cytoplasm of cells. Since many cancers up-regulate the FR it has enabled the targeting of toxins to tumor cells resulting in specific cell death. However, current conjugation methods rely on ... More
Site-specific modifications of light chain glycosylated antilymphoma (LL2) and anti-carcinoembryonic antigen (hImmu-14-N) antibody divalent f1agments.
Authors:Govindan SV, Goldenberg DM, Griffiths GL, Leung SO, Losman MJ, Hansen HJ
Journal:Cancer Res
PubMed ID:7493334
Site-specific introduction of metal-chelating groups into F(ab')2 fragments of an antilymphoma antibody (LL2) possessing a natural Asn-linked light chain carbohydrate and an anti-carcinoembryonic antigen antibody (hImmu-14-N) grafted with a light chain carbohydrate site is described. For this purpose, four yttrium- (and indium)-chelating agents were used, containing a primary amino group ... More